Navigation Links
Nexavar Approved in Japan for the Treatment of Advanced Liver Cancer
Date:5/20/2009

ed that Raf/MEK/ERK has a role in HCC; therefore blocking signaling through Raf-1 may offer therapeutic benefits in HCC.

Nexavar is currently approved in more than 70 countries for liver cancer and in more than 80 countries for the treatment of patients with advanced kidney cancer. Nexavar is also being evaluated by the companies, international study groups, government agencies and individual investigators as a single agent or combination treatment in a wide range of cancers, including, lung cancer, breast cancer, colorectal cancer, lung cancer, ovarian cancer, and as an adjuvant therapy for kidney and liver cancer.

Important Safety Considerations For Patients Taking Nexavar

Based on the currently approved U.S. package insert for the treatment of patients with unresectable hepatocellular carcinoma, hypertension may occur early in the course of therapy and blood pressure should be monitored weekly during the first six weeks of therapy and treated as needed. Bleeding with a fatal outcome from any site was reported in 2.4% for Nexavar and 4% in placebo. The incidence of treatment-emergent cardiac ischemia/infarction was 2.7% for Nexavar vs. 1.3% for placebo. Most common adverse events reported with Nexavar in patients with unresectable HCC were diarrhea, fatigue, abdominal pain, weight loss, anorexia, nausea and hand-foot skin reaction. Grade 3/4 adverse events were 45% for Nexavar vs. 32% for placebo. Women of child-bearing potential should be advised to avoid becoming pregnant and advised against breast-feeding. In cases of any severe or persistent side effects, temporary treatment interruption, dose modification or permanent discontinuation should be considered.

For information about Nexavar including U.S. Nexavar prescribing information, visit www.nexavar.com or call 1.866.NEXAVAR (1.866.639.2827).

About Bayer Heal
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals; Onyx Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. New Analyses Confirm Nexavars Efficacy and Safety in Multiple Patient Subsets With Liver Cancer
2. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar; Previously Announced Fourth Quarter and Full Year 2007 Financial Results Teleconference Rescheduled
3. Career Step Approved to Train Military Spouses with Department of Defense CAA Funds
4. Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise
5. IQAir HealthPro Plus Wins Parent Tested Parent Approved Seal of Approval Award
6. Nektar Announces UCBs Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
7. UCBs CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
8. MedClean Technologies, Inc. Approved in New Jersey
9. GADA Points to Safety of FDA Approved Generics in Wake of Wellington Polo Horse Deaths from Compounded Drugs
10. DRAXIMAGE(R)s generic Sestamibi Approved for launch in USA
11. New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- U.S. and ... to caramel apples that has killed at least four ... Consumers should not eat any commercially produced, prepackaged caramel ... for Disease Control and Prevention said in a news ... 28 people had been infected with the outbreak strains ...
(Date:12/22/2014)... 2014 Physicians in China are most ... treatment of non-Hodgkin’s lymphoma (NHL), according to a new ... healthcare consulting firm. MabThera is the only biologic available ... common form of NHL. , According to Kantar Health’s ... incidence of NHL in China has been growing and ...
(Date:12/22/2014)... Colorado (PRWEB) December 22, 2014 Super ... Black Friday this year as the busiest day in ... other retailers, The Grass Station had a steady pre-Christmas ... holiday gifts, this past Saturday. , “I definitely intend ... 33-year-old Robert, a Denver resident who was enjoying The ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Only weeks ... southern and mid-western cities to have a battery manufacturer ... TalkLocal ( http://www.talklocal.com ) is launching in Henderson ... economy. , “A strong manufacturing sector is going ... founder Gurpreet Singh explained, “and TalkLocal works with small ...
(Date:12/22/2014)... In recognition of Veteran’s Day, Discount Labels ... a local organization that provides services to veterans and ... on a couple hundred acres in the hills of ... class fishing, hunting, hiking, horseback riding, 4-wheeling, skeet shooting, ... ago to support U.S. Service men and women, police ...
Breaking Medicine News(10 mins):Health News:CDC Warns of Listeria Danger From Caramel Apples 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2
... Capital BlueCross announced today that it will cover an ... and those with individual coverage during the upcoming 2009-2010 flu ... to include this benefit. , , A ... October. Various clinical vaccine trials have begun, some under the ...
... NEW YORK, Sept. 16 Dr. Mark Hasten, chairman of the ... Kadish, M.D., as senior provost and chief operating officer for Touro ... http://www.flickr.com/photos/tourocollege/3923514965/ , , Touro is ... college was founded by Dr. Bernard Lander in 1970, originally as ...
... , FARMINGTON HILLS, Mich., Sept. ... stock and assets of GTL, Inc. dba as "Link to ... product and service offerings into CST to provide cost-effective personal ... and quality of life for older adults, the disabled and ...
... 20% of emergency room visits and 5% of ... first-line treatment option in patients with gastrointestinal bleeding, ... diagnostic and treatment method in patients with gastrointestinal ... incidence of rebleeding in patients with negative initial ...
... HEATHROW, Fla., Sept. 16 Cozmix, Inc., a sales ... beta release of SizeMix, the sales industry,s first point and ... forms a core component of Cozmix, SizeMix Process. , ... components necessary to complete a full internal review of a ...
... , BALTIMORE, Sept. 16 While most men ... likely unaware of other important statistics that could one day save ... and the National Football League (NFL) are teaming to encourage men ... of cancer death for American men. Men and their loved ones ...
Cached Medicine News:Health News:Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season 2Health News:Touro Appoints Alan Kadish, M.D., Senior Provost and Chief Operating Officer 2Health News:Touro Appoints Alan Kadish, M.D., Senior Provost and Chief Operating Officer 3Health News:Touro Appoints Alan Kadish, M.D., Senior Provost and Chief Operating Officer 4Health News:Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth, Personal Emergency Response and Medical Monitoring Systems 2Health News:Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth, Personal Emergency Response and Medical Monitoring Systems 3Health News:Sales Force Sizing and Resource Optimization Software Is the First of Its Kind to Enter the Market (Beta Release) 2Health News:Video: NFL Season Kicks Off With Campaign to 'Know Your Stats About Prostate Cancer' 2Health News:Video: NFL Season Kicks Off With Campaign to 'Know Your Stats About Prostate Cancer' 3Health News:Video: NFL Season Kicks Off With Campaign to 'Know Your Stats About Prostate Cancer' 4
(Date:12/22/2014)... , Dec. 22, 2014 Research and ... the addition of the "Investment Analysis of ... to their offering. ... in the US medical device sector identifies the ... and venture capital investments, and mergers and acquisitions. ...
(Date:12/22/2014)... CHESTERBROOK, Pa. and STOCKHOLM ... AB (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today ... Use (CHMP) of the European Medicines Agency (EMA) has ... (collagenase clostridium histolyticum) for the treatment of adult men ... deformity of at least 30 degrees at the start ...
(Date:12/22/2014)... PALO ALTO, Calif. , Dec, 22, 2014 ... of a Phase 2a study of lonafarnib in ...  The study was conducted at the National Institutes ... Bethesda, Maryland .  The double-blinded, randomized, placebo-controlled, ... 100 mg twice daily and 200 mg twice ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... Aug. 23 Biopure Corporation,(Nasdaq: BPUR ) ... clinical,study protocol to the FDA for compassionate use ... States. The proposed open label,study would make Hemopure ... or potentially life threatening anemia on a compassionate ...
... Alfacell Corporation,(Nasdaq: ACEL ) today announced that ... (2007; Vol. 31, Issue 3: 663-669) reports that,ONCONASE(R) ... types and tumor cell lines. The observed antioxidant ... effect on cancer cells and,mechanistic synergism with other ...
Cached Medicine Technology:Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia 2Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia 3Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 2Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 3
Ballard trach care HMES and filters, tv 1500, HME with built-in flex tube...
... Portex® Thermovent® T helps provide protection to the ... small and extremely lightweight making it ideal for ... a high rate of heat and moisture recovery, ... ,All HMEs and filters have ISO standard ...
... protection to the exposed airway of the tracheostomy ... it ideal for active young children as well ... and moisture recovery, it ensures patient comfort and ... have ISO standard tapered ends to assure a ...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
Medicine Products: